References
- World Health Organization. Coronavirus disease 2019 (COVID-19) situation report. 50. https://www.who.int/docs/default-source/coronavirus/situationreports/20200310-sitrep-50-covid-19.pdf?sfvrsn=55e904fb. Published March 10, 2020. Accessed July, 2020.
- Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi:https://doi.org/10.1056/NEJMoa2001017.
- Chu HY, Englund JA, Starita LM, et al. Early detection of COVID-19 through a citywide pandemic surveillance platform. N Engl J Med. 2020;383(2):185–187. doi:https://doi.org/10.1056/NEJMc2008646.
- Mackenzie JS, Smith DW. COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don’t. Microbiol Aust. 2020;17:MA20013. doi:https://doi.org/10.1071/MA20013.
- Guo Y-R, Cao Q-D, Hong Z-S, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Mil Med Res. 2020;7(1):11. doi:https://doi.org/10.1186/s40779-020-000-0.
- Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:https://doi.org/10.1016/S0140-6736(20)30566-3.
- Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi:https://doi.org/10.1056/NEJMoa2002032.
- Woo PCY, Lau SKP, Lam CSF, et al. Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and delta coronavi. J Virol. 2012;86(7):3995–4008. doi:https://doi.org/10.1128/JVI.06540-11.
- Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol. 2015;1282:1–23. doi:https://doi.org/10.1007/978-14939-2438-7_1.
- Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181(2):281–292. doi:https://doi.org/10.1016/j.cell.2020.02.058.
- Xu H, Zhong L, Deng J, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020;12(1):8. doi:https://doi.org/10.1038/s41368-020-0074.
- Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020;92(6):589–594. doi:https://doi.org/10.1002/jmv25725.
- Xie H-T, Jiang S-Y, Xu -K-K, et al. SARS-CoV-2 in the ocular surface of COVID-19 patients. Eye Vis. 2020;7:23. doi:https://doi.org/10.1186/s40662-020-00189-0.
- Tay MZ, Poh CM, Renia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;20(6):363–374. doi:https://doi.org/10.1038/s41577-020-0311-8.
- Cheema M, Aghazadeh H, Nazarali S, et al. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can J Ophthalmol. 2020;55(4):e125–e129. doi:https://doi.org/10.1016/j.jcjo.2020.03.003.
- Wu P, Duan F, Luo C, et al. Characteristics ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei province, China. Jama Ophthalmol. 2020;138(5):575–578. doi:https://doi.org/10.1001/jamaophthalmol.2020.1291.
- Inomata T, Kitazawa K, Kuno T, et al. Clinical and prodromal ocular symptoms in coronavirus disease: a systematic review and meta-analysis. Invest Ophthalmol Vis Sci. 2020;61(10):29. doi:https://doi.org/10.1167/iovs.61.10.29.
- Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronavirus and ocular implications in humans and animals. Ocul Immunol Inflamm. 2020;28(3):391–395. doi:https://doi.org/10.1080/09273948.2020.1738501.
- Cheong KX. Systematic review of ocular involvement of SARS-CoV-2 in coronavirus disease 2019. Curr Ophthalmol Rep. 2020;1–10. doi:https://doi.org/10.1007/s40135-020-00257-7.
- Hong N, Yu W, Xia J, Shen Y, Yap M, Han W. Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19. Acta Ophthalmol. 2020;98. doi:https://doi.org/10.1111/aos.14445.
- Danthuluri V, Grant MB. Update and recommendations for ocular manifestations of COVID-19 in adults and children: a narrative review. Ophthalmol Ther. 2020;9(4):853–875. doi:https://doi.org/10.1007/s40123-020-00310-5.
- Seah IYJ, Anderson DE, Kang AEZ, et al. Assessing viral shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients. Ophthalmology. 2020;127(7):977–979. doi:https://doi.org/10.1016/j.ophta.202003.036.
- Lu CW, Liu XF, Jia ZF. 2019 nCov transmission through the ocular surface must not be ignored. Lancet. 2020;395(10224):e39. doi:https://doi.org/10.1016/S0140-6736(20)30313-5.
- Sun C-B, Wang -Y-Y, Liu G-H, Liu Z. Role of the eye in transmitting human coronavirus: what we know and what we do not know. Front Public Health. 2020;8:155. doi:https://doi.org/10.3389/fpubh.2020.00155.
- Colavita F, Lapa D, Carletti F, et al. SARS-CoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection. Ann Intern Med. 2020;173(3):242–243. doi:https://doi.org/10.7326/M20-1176.
- Ho D, Low R, Tong L, Gupta V, Veeraraghavan A, Agrawal R. COVID-19 and the ocular surface: a review of transmission and manifestations. Ocul Immunol Inflamm. 2020;28(5):726–734. doi:https://doi.org/10.1080/09273948.2020.1772313.
- Paulsen F. Functional anatomy and immunological interactions ocular surface and adnexa. Dev Ophthalmol. 2008;41:21–35. doi:https://doi.org/10.1159/000131068.
- Mantelli F, Mauris J, Argueso P. The ocular surface epithelial barrier and other mechanisms of mucosal protection: from allergy to infectious diseases. Curr Opin Allergy Clin Immunol. 2013;13(5):563–568. doi:https://doi.org/10.1097/ACI.0b013e3283645899.
- Meduri A, Oliverio GW, Mancuso G, et al. Ocular surface manifestation of COVID-19 and tear film analysis. Sci Rep. 2020;10(1):20178. doi:https://doi.org/10.1038/s41598-020-77194-9.
- Karimi S, Arabi A, Shahraki T, Safi S. Detection of severe acute respiratory syndrome coronavirus-2 in the tears of patients with coronavirus disease 2019. Eye (Lond). 2020;34(7):1220–1223. doi:https://doi.org/10.1038/s41433-020-0965-2.
- Amesty MA, Alio Del Barrio JL, Alio JL. COVID-19 disease and ophthalmology: an update. Ophthalmol Ther. 2020;9(3):415–426. doi:https://doi.org/10.1007/s40123-020-00260-y.
- Sarıtaş TB, Bozkurt B, Şimşek B, Çakmak Z, Özdemir M, Yosunkaya A. Ocular surface disorders in intensive care unit patients. Sci World J. 2013;182038. doi:https://doi.org/10.1155/2013/182038.
- Bertoli F, Veritti D, Danese C, et al. Ocular findings in COVID-19 patients: a review of direct manifestations and indirect effects on the eye. J Ophthalmol. 2020;4827304. doi:https://doi.org/10.1155/2020/4827304.
- Hernandez EV, Mannis MJ. Superficial keratopathy in intensive care unit patients. Am J Ophthalmol. 1997;124(2):212–216. doi:https://doi.org/10.1016/s0002-9394(14)70786-x.
- Douglas KAA, Douglas VP, Moschos MM. Ocular manifestations of COVID-19 (SARS-CoV-2): a critical review of current literature. In vivo. 2020;34(3):1619–1628. doi:https://doi.org/10.21873/invivo.11952.
- Panchabhai T, Bandyopadhyay D, Kapoor A, Akindipe O, Lane C, Krishnan S. Acute ischemic optic neuropathy with extended prone position ventilation in a lung transplant recipient. Int J Crit Illn Inj Sci. 2016;6(1):45–47. doi:https://doi.org/10.4103/2229-5151.177367.
- Cheng MA, Todorov A, Tempelhoff R, McHugh T, Crowder CM, Lauryssen C. The effect of prone positioning on intraocular pressure in anesthetized patients. Anesthesiology. 2001;95(6):1351–1355. doi:https://doi.org/10.1097/00000542-200112000-00012.
- Butty Z, Gopwani J, Mehta S, Margolin E. Horner’s syndrome in patients admitted to the intensive care unit that have undergone central venous catheterization: a prospective study. Eye(Lond). 2016;30(1):31–33. doi:https://doi.org/10.1038/eye.2015.181.
- Ma N, Li P, Wang X, et al. Ocular manifestations and clinical characteristics of children with laboratory-confirmed COVID-19 in Wuhan, China. Jama Ophthalmol. 2020;138(10):1079–1086. doi:https://doi.org/10.1001/jamaophthalmol.2020.3690.
- Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109(6):1088–1095. doi:https://doi.org/10.1111/apa.15270.
- Karimi-Zarchi M, Neamatzadeh H, Dastgheib SA, et al. Vertical transmission of coronavirus disease 2019 (COVID-19) from infected pregnant mothers to neonates: a review. Fetal Pediatr Pathol. 2020;39(3):246–250. doi:https://doi.org/10.1080/15513815.2020.1747120.
- Navel V, Chiambaretta F, Dutheil F. Haemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2. Am J Ophthalmol Case Rep. 2020;19:100735. doi:https://doi.org/10.1016/j.ajoc.2020.100735.
- Salducci M, La Torre G. COVID-19 emergency in the cruise’s ship: a case report of conjunctivitis as the first symptom. Clin Ter. 2020;171:e189–e191.
- Otaif W, Somali AI, Habash A. Episcleritis as a possible presenting sign of the novel coronavirus disease: a case report. Am J Ophthalmol Case Rep. 2020;20:100917. doi:https://doi.org/10.1016/j.ajoc.2020.100917.
- Luis ME, Hipolito-Fernandes D, Mota C, et al. A review of neuro-ophthalmological manifestations of human coronavirus infection. Eye Brain. 2020;12:129–137. doi:https://doi.org/10.2147/EB.
- Dinkin M, Gao V, Kahan J, et al. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology. 2020;95(5):221–223. doi:https://doi.org/10.1212/WNL0000000000009700.
- Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683–690. doi:https://doi.org/10.1001/jamaneurol.2020.1127.
- Xiang P, Xu X, Gao L, et al. First case of 2019 novel coronavirus disease with encephalitis. ChinaXiv. 2020;61.
- Bigaut K, Mallaret M, Baloğlu S, et al. Guillain-Barre syndrome related to SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e785. doi:https://doi.org/10.1212/NXI.0000000000000785.
- Camano DSJ, Beato RA. Facial diplegia, a possible atypical variant of Guillain-Barre syndrome as a rare neurological complication of SARS-CoV-2. J Clin Neurosci. 2020;77:230–232. doi:https://doi.org/10.1016/j.jocn.2020.05.016.
- Gutierrez-Ortiz C, Mendez-Guerrero A, Rodrigo-Rey S, et al. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020;95(5):e601–e605.
- Pollitero SE, Ferrer-Bergua LG. Paciente con clinica neurologica como unica manifestacion infeccion por SARS-CoV-2. Neurologia. 2020. doi:https://doi.org/10.1016/j.nrl.2020.04.010.
- Belgmaidi S, Nassih H, Boutgayout S, et al. Third cranial nerve palsy presenting with unilateral diplopia and strabismus in a 24-year-old woman with COVID-19. Am J Case Rep. 2020;21:e925897. doi:https://doi.org/10.12659/AJCR915897.
- Wei H, Yin H, Huang M, Guo Z. The 2019 novel coronavirus pneumonia with onset of oculomotor nerve palsy: a case study. J Neurol. 2020;267(5):1550–1553. doi:https://doi.org/10.1007/s00415-020-09773-9.
- Falcone MM, Rong AJ, Salazar H, Redick DW, Falcone S, Cavuoto KM. Acute abducens nerve palsy in a patient with the novel coronavirus disease (COVID-19). JAAPOS. 2020;24(4):216–217. doi:https://doi.org/10.1016/j.jaapos.2020.06.001.
- Ortiz-Seller A, Martinez Costa L, Hernandez-Pons A, Valls Pascual E, Solves-Alemany A, Albert-Fort M. Ophthalmic and neuro-ophthalmic manifestations of coronavirus disease 2019 (COVID-19). Ocul Immunol and Inflamm. 2020;28(8):1285–1289. doi:https://doi.org/10.1080/09273948.2020.1817497.
- Marinho PM, Marcos AAA, Romano AC, Nascimento H, Belfort R Jr. Retinal findings in patients with COVID-19. Lancet. 2020;395(10237):1610. doi:https://doi.org/10.1610/S0140-6736(20)31014-X.
- Vavvas DG, Sarraf D, Sadda SR, et al. Concerns about the interpretation of OCT and fundus findings in COVID-19 patients. Lancet. 2020;34(12):2153–2154. doi:https://doi.org/10.1038/s41433-020-1084-9.
- Gavriilaki E, Brodsky RA. Severe COVID-19 infection thrombotic microangiopathy: success does not come easily. Br J Haematol. 2020;189(6):e227–e230. doi:https://doi.org/10.1111/bjh.16783.
- Hönemann C, Brandt L. Valsalva retinopathy. A rare complication after general anesthesia. Case Rep. 2015;5(12):231–233. doi:https://doi.org/10.1213/XAA.0000000000000245.
- Invernizzi A, Torre A, Parrulli S, et al. Retinal findings in patients with COVID-19: results from the SERPICO-19 study. EClinicalMedicine. 2020;27:100550. doi:https://doi.org/10.1016/j.eclinm.2020.100550.
- Pereira LA, Soares LCM, Nascimento PA, et al. Retinal findings in hospitalized patients with severe COVID-19. Br J Ophthalmol. 2020;16: bjophthalmol-2020-317576. doi:https://doi.org/10.1136/bjophthalmol-2020-317576.
- Insausti-Garcia A, Reche-Sainz JA, Ruiz-Arranz C, Vazquez AL, Ferro-Osuna M. Papillophlebitis in a COVID-19 patient: inflammation and hypercoagulable state. Eur J Ophthalmol. 2020;1120672120947591. doi:https://doi.org/10.1177/1120672120947591.
- Acharya S, Diamond M, Anwar S, Glaser A, Tyagi P. Unique case of central retinal artery occlusion secondary to COVID-19 disease. IDCases. 2020;21:e00867. doi:https://doi.org/10.1016/j.idcr.2020.e00867.
- Yahalomi T, Pikkel J, Arnon R, Pessach Y. Central retinal vein occlusion in a young healthy COVID-19 patient: a case report. Am J Ophthalmol Case Rep. 2020;20:100992. doi:https://doi.org/10.1016/j.ajoc.2020.100992.
- Barosso G, Morbio R, Chemello F, Tosi R, Marchini G. Bilateral angle-closure during hospitalization for coronavirus disease-19 (COVID-19): a case report. Eur J Ophthalmol. 2021;112067212110121. doi:https://doi.org/10.1177/11206721211012197.
- Verdoni L, Mazza A. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1607–1608. doi:https://doi.org/10.1016/S0140-6736(20)31103-X.
- Holappa M, Vapaatalo H, Vaajanen A. Many faces of renin-angiotensin system–focus on eye. Open Ophthalmol J. 2017;11:122–142. doi:https://doi.org/10.2174/1874364101711010122.
- Türbin RE, Wawrzusin PJ, Sakla NM, et al. Orbital cellulitis, sinusitis and intracranial abnormalities in two adolescents with COVID-19. Orbit. 2020;39(4):305–310. doi:https://doi.org/10.1080/01676830.2020.1768560.
- Azari AA, Barney NP. Conjunctivitis: a systematic review of diagnosis and treatment. JAMA. 2013;310(16):1721–1729. doi:https://doi.org/10.1001/jama.2013.280318.
- Shetty R, D’Souza S, Lalgudi VG. What ophthalmologists should know about conjunctivitis in the COVID-19 pandemic. Ind J Ophthalmol. 2020;68(5):683–687. doi:https://doi.org/10.4103/ijo.IJO_869_20.
- Labib BA, Minhas BK, Chigbu DI. Management of adenoviral keratoconjunctivitis: challenges and solutions. Clin Ophthalmol. 2020;14:837–852. doi:https://doi.org/10.2147/OPTH.S207976.
- EUA Hydroxychloroquine Sulfate Health Care Provider Fact Sheet. The U.S. Food and Drug Administration (FDA). https://www.fda.gov/media/136537/download. Accessed June 15, 2020.
- EUA Chloroquine Phosphate Health Care Provider Fact Sheet. The U.S. Food and Drug Administration (FDA). https://www.fda.gov/media/136535/download. Accessed June 15, 2020.
- Stokkermans TJ, Trichonas G. Chloroquine and Hydroxychloroquine Toxicity. Treasure Island, FL: StatPearls Publishing; 2020. https://www.ncbi.nlm.nih.gov/books/NBK537086/ .
- Marmor MF, Kellner U, Lai TYY, Melles RB, Mieler WF. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology. 2016;123(6):1386–1394. doi:https://doi.org/10.1016/j.ophtha.2016.01.058.
- Roe RH, Jumper JM, Gualino V, et al. Retinal pigment epitheliopathy, macular telangiectasis and intraretinal crystal deposits in HIV-positive patients receiving ritonavir. Retina. 2011;31(3):559–565. doi:https://doi.org/10.1097/IAE.0b013e3181f042c4.
- Schulman JA, Liang C, Kooragayala LM, King J. Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin. Ophthalmology. 2003;110(2):437–442. doi:https://doi.org/10.1016/S0161-6420(02)01741-4.
- Bryant A, Lawrie TA, Dowswell T, et al. Ivermectin for prevention and treatment of COVID-19 infection: a systematic review and meta-analysis, and trial sequential analysis to inform clinical guidelines. Am J Ther. 2021;28(4):e434–e460. doi:https://doi.org/10.1097/MJT.0000000000001402.
- Wong RLM, Ting DSW, Wan KH, et al. COVID-19: ocular manifestations and the APAO prevention guidelines for ophthalmic practices. Asia Pac J Ophthalmol. 2020;9(4):281–284. doi:https://doi.org/10.1097/APO.0000000000000308.
- Chu DK, Akl EA, Duda S, et al. Physical distancing, face masks and eye protection prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta- analysis. Lancet. 2020;395(10242):1973–1987. doi:https://doi.org/10.1016/S0140-6736(20)31142-9.
- Lai THT, Tang EWH, Chau SKY, Fung KSC, Li KKW. Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong. Graefe’s Arch Clin Exp Ophthalmol. 2020;258(5):1049–1055. doi:https://doi.org/10.1007/s00417-020-04641-8.
- Li JPO, Shantha J, Wong TY, et al. Preparadness among ophthalmologists: during and beyond the COVID-19 pandemic. Ophthalmology. 2020;127(5):569–572. doi:https://doi.org/10.1016/j.ophta.2020.03.037.
- Nuzzi R, Carucci LL, Tripoli F. COVID-19 and ocular implications: an update. J Ophthalmic Inflamm Infect. 2020;10(1):20. doi:https://doi.org/10.1186/s12348-020-00212-4.
- Liu J, Wang AY, Ing EB. Efficacy of slit lamp breath shields. Am J Ophthalmol. 2020;218:120–127. doi:https://doi.org/10.1016/j.ajo.2020.05.005.
- Britt JM, Clifton BC, Barnebey HS, Mills RP. Microaerosol formation in noncontact air-puff tonometry. Arch Ophthalmol. 1991;109(2):225–228. doi:https://doi.org/10.1001/archopht.1991.01080020071046.